【レポートの概要（一部）】
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 4
1.2 List of Figures 7
2 Introduction 8
2.1 Multiparameter Patient Monitoring Overview 8
3 Products under Development 10
3.1 Multiparameter Patient Monitoring – Pipeline Products by Stage of Development 10
3.2 Multiparameter Patient Monitoring – Pipeline Products by Segment 11
3.3 Multiparameter Patient Monitoring – Pipeline Products by Territory 12
3.4 Multiparameter Patient Monitoring – Pipeline Products by Regulatory Path 13
3.5 Multiparameter Patient Monitoring – Pipeline Products by Estimated Approval Date 14
3.6 Multiparameter Patient Monitoring – Ongoing Clinical Trials 15
4 Multiparameter Patient Monitoring – Pipeline Products under Development by Companies 16
4.1 Multiparameter Patient Monitoring Companies – Pipeline Products by Stage of Development 16
4.2 Multiparameter Patient Monitoring – Pipeline Products by Stage of Development 18
5 Multiparameter Patient Monitoring Companies and Product Overview 20
5.1 Azoi Inc. Company Overview 20
5.1.1 Azoi Inc. Pipeline Products & Ongoing Clinical Trials Overview 20
5.2 Bio-Impedance General Ltd. Company Overview 21
5.2.1 Bio-Impedance General Ltd. Pipeline Products & Ongoing Clinical Trials Overview 21
5.3 BioNovus Technologies, LLC Company Overview 22
5.3.1 BioNovus Technologies, LLC Pipeline Products & Ongoing Clinical Trials Overview 22
5.4 Biovotion AG Company Overview 23
5.4.1 Biovotion AG Pipeline Products & Ongoing Clinical Trials Overview 23
5.5 Chinese University of Hong Kong Company Overview 25
5.5.1 Chinese University of Hong Kong Pipeline Products & Ongoing Clinical Trials Overview 25
5.6 CorTronix Biomedical Advancement Technologies, Inc. Company Overview 28
5.6.1 CorTronix Biomedical Advancement Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 28
5.7 EarlySense, Inc. Company Overview 29
5.7.1 EarlySense, Inc. Pipeline Products & Ongoing Clinical Trials Overview 29
5.8 Edwards Lifesciences Corporation Company Overview 30
5.8.1 Edwards Lifesciences Corporation Pipeline Products & Ongoing Clinical Trials Overview 30
5.9 Fraunhofer-Institut fur Integrierte Schaltungen Company Overview 32
5.9.1 Fraunhofer-Institut fur Integrierte Schaltungen Pipeline Products & Ongoing Clinical Trials Overview 32
5.10 Hope College Company Overview 33
5.10.1 Hope College Pipeline Products & Ongoing Clinical Trials Overview 33
5.11 iHealth Lab Inc Company Overview 34
5.11.1 iHealth Lab Inc Pipeline Products & Ongoing Clinical Trials Overview 34
5.12 Institute for Infocomm Research Company Overview 36
5.12.1 Institute for Infocomm Research Pipeline Products & Ongoing Clinical Trials Overview 36
5.13 Intelesens Ltd. Company Overview 37
5.13.1 Intelesens Ltd. Pipeline Products & Ongoing Clinical Trials Overview 37
5.14 Kyushu University Company Overview 39
5.14.1 Kyushu University Pipeline Products & Ongoing Clinical Trials Overview 39
5.15 LifeWatch Technologies, Ltd. Company Overview 40
5.15.1 LifeWatch Technologies, Ltd. Pipeline Products & Ongoing Clinical Trials Overview 40
5.16 Monitor-it S.A. Company Overview 42
5.16.1 Monitor-it S.A. Pipeline Products & Ongoing Clinical Trials Overview 42
5.17 NeMoDevices AG Company Overview 43
5.17.1 NeMoDevices AG Pipeline Products & Ongoing Clinical Trials Overview 43
5.18 PneumoSonics Inc. Company Overview 47
5.18.1 PneumoSonics Inc. Pipeline Products & Ongoing Clinical Trials Overview 47
5.19 Quanttus, Inc Company Overview 48
5.19.1 Quanttus, Inc Pipeline Products & Ongoing Clinical Trials Overview 48
5.20 REALTROMINS, Inc Company Overview 49
5.20.1 REALTROMINS, Inc Pipeline Products & Ongoing Clinical Trials Overview 49
5.21 Rice University Company Overview 53
5.21.1 Rice University Pipeline Products & Ongoing Clinical Trials Overview 53
5.22 Scanadu HQ Company Overview 55
5.22.1 Scanadu HQ Pipeline Products & Ongoing Clinical Trials Overview 55
5.23 Snap40 Limited Company Overview 56
5.23.1 Snap40 Limited Pipeline Products & Ongoing Clinical Trials Overview 56
5.24 Sotera Wireless, Inc. Company Overview 57
5.24.1 Sotera Wireless, Inc. Pipeline Products & Ongoing Clinical Trials Overview 57
5.25 Sphere Medical Limited Company Overview 58
5.25.1 Sphere Medical Limited Pipeline Products & Ongoing Clinical Trials Overview 58
5.26 Toshiba Medical Systems Corporation Company Overview 60
5.26.1 Toshiba Medical Systems Corporation Pipeline Products & Ongoing Clinical Trials Overview 60
5.27 University of Illinois Company Overview 62
5.27.1 University of Illinois Pipeline Products & Ongoing Clinical Trials Overview 62
5.28 University of Oxford Company Overview 64
5.28.1 University of Oxford Pipeline Products & Ongoing Clinical Trials Overview 64
5.29 University of Technology Sydney Company Overview 65
5.29.1 University of Technology Sydney Pipeline Products & Ongoing Clinical Trials Overview 65
5.30 University of Washington Company Overview 66
5.30.1 University of Washington Pipeline Products & Ongoing Clinical Trials Overview 66
5.31 Vasomedical, Inc. Company Overview 67
5.31.1 Vasomedical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 67
5.32 Vios Medical, Inc. Company Overview 69
5.32.1 Vios Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 69
5.33 Worcester Polytechnic Institute Company Overview 70
5.33.1 Worcester Polytechnic Institute Pipeline Products & Ongoing Clinical Trials Overview 70
6 Multiparameter Patient Monitoring- Recent Developments 71
7 Appendix 160
7.1 Methodology 160
7.2 About GlobalData 162
7.3 Contact Us 162
7.4 Disclaimer 162
【レポート販売概要】
■ タイトル：世界における多重パラメータ患者モニタリング機器の製品パイプライン動向2015■ 英文：Multiparameter Patient Monitoring - Pipeline Review, 2015
■ 発行日：2015年5月25日
■ 調査会社：GlobalData
■ 商品コード：GDME0009EPD
■ 調査対象地域：グローバル
- 義歯の世界市場2019-2023About this market Edentulism or tooth loss is a condition characterized by the partial or complete loss of teeth as a result of injury or diseases such as tooth decay, tooth trauma, or gum disease. Edentulism is common among older people and affects the person's facial appearance and ability to eat and talk. Also, the growing incidence of causative factors on dental health such as smoking, alcohol …
- ワクチンの世界市場：小児用ワクチン、成人用ワクチンVaccines and their technology – your guide to developments, opportunities and revenues See what the future holds for vaccines. Visiongain’s updated report lets you assess forecasted sales at overall world market, submarket, product and national level to 2025. Make sure you understand trends, R&D, opportunities and prospects there, in human medicine. That way you can help your research, analysis an …
- 世界及び米国の金産業動向：Focusing on Gold and the US Gold IndustryGold is a highly sought-after precious metal which, for many centuries, has been used as money, a store of value and in jewelry. The metal occurs as nuggets or grains in rocks, underground "veins" and in alluvial deposits. Gold forms the basis for a monetary standard used by the International Monetary Fund (IMF) and the Bank for International Settlements (BIS). Modern industrial uses include denti …
- ポリデキストロースの世界市場Polydextrose (CAS 68424-04-4) Market Research Report 2014 presents comprehensive data on polydextrose markets globally and regionally (Europe, Asia, North America etc.) The report includes polydextrose description, covers its application areas and related patterns. It overviews polydextrose market, names polydextrose producers and indicates its suppliers. Besides, the report provides polydextrose …
- 無線キャリアの加入者、スペクトラム、オーナーシップ、インフラデータベース（Mobile Operator Subscriptions, Spectrum, Ownership & Infrastructure Contracts Database Q1'2012）This database (Excel spreadsheet) provides in-depth information focused on mobile network operator subscriptions and cellular wireless technologies being deployed around the world. Covering over 800 global mobile network operators, it provides summary data by operator, technology, data protocol, country and region for quick analysis of trends using a combination of subscriptions, infrastructure co …
- 電気自動車走行用モーターの世界市場2015-2019About EV traction motor EV traction motor is an electric motor that is used for the propulsion of EVs. It converts electrical energy into motion. These traction motors form a major component in EVs such as cars, two-wheelers, light industrial/commercial vehicles, military vehicles, buses, and others. These motors determine the performance and affordability of EVs. Technavio's analysts forecast the …
- 残留試験の世界市場予測（～2021年）：農薬、毒素、重金属、アレルゲンThe residue testing market size is projected to reach USD 4.41 Billion by 2021, at a CAGR of 6.4% from 2016. The market is driven by increasing outbreaks of chemical contamination in foods, growing allergic reactions among children and adults, global movement of organic revolution, implementation of food safety regulations, and international trade of food materials. The residue testing market, bas …
- 世界主要国におけるエンテロウイルス検査市場2015The report presents a detailed analysis of the Enterovirus diagnostics market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Enterovirus definition, epidemiology and etiology are reviewed. The report provides the 5-year test volume and sales forecasts by country for the following market segments: - Hospitals - …
- 紙 ・板紙容器及びパッケージの世界市場2015-2019About Paper and Paperboard Container and Packaging Paper and paperboard packaging is an emerging trend in the Packaging industry. It is gaining importance in many regions as it is environment friendly and cost-effective. Paperboard is thicker with a high weight per unit area and is made in multiple layers. It is mostly used to make containers such as boxes, cartons, and trays for packaging and shi …
- 水添レシチンの世界市場2015Lecithin, hydrogenated (CAS 92128-87-5) Market Research Report 2015 aims at providing comprehensive data on Lecithin, hydrogenated market globally and regionally (Europe, Asia, North America, Latin America etc.) The report includes Lecithin, hydrogenated description, covers its application areas, manufacturing methods, patterns. It captures Lecithin, hydrogenated market trends, pays close attentio …
- 非アルコール性脂肪肝炎(NASH)：市場機会分析及び予測（～2018）OpportunityAnalyzer: Nonalcoholic Steatohepatitis (NASH) - Opportunity Analysis and Forecasts to 2017 - Event-Driven Update Summary GlobalData has released its new Opportunity Analyzer report, “OpportunityAnalyzer: Nonalcoholic Steatohepatitis (NASH) - Opportunity Analysis and Forecasts to 2017 - Event-Driven Update”. The NASH market is currently deserted and awaits its first NASH-specific therapy …
- 世界のミサイル及びミサイル防衛システムの市場動向2013-2023Why was the report written? “The Global Missiles and Missile Defense Systems Market 2013-2023” offers the reader detailed analysis of the global missiles and missile defense systems market over the next ten years, alongside potential market opportunities to enter the industry, using detailed market size forecasts. What are the key drivers behind recent market changes? The US has witnessed budget c …
- 防水用化学品の世界市場：ビチューメン、エラストマー、PVC、TPO、EPDMThe waterproofing chemicals market is projected to reach USD 30.88 Billion by 2021, at a CAGR of 12.1%. The market is driven by the increase in governmental policies boosting infrastructure growth, improving economics and quality of construction and high demand in developing nations. However, the mature markets of Europe and North America are projected to witness slow growth during the forecast pe …
- ブラジル・ロシア・インド・中国の頭蓋顎顔面固定(CMF)手術動向（～2020）BRIC Cranio Maxillofacial Fixation (CMF) Procedures Outlook to 2020 Summary GlobalData’s new report, "BRIC Cranio Maxillofacial Fixation (CMF) Procedures Outlook to 2020", provides key procedures data on the BRIC Cranio Maxillofacial Fixation (CMF) Procedures. The data in the report is derived from dynamic market forecast models. GlobalData uses epidemiology based models to estimate and forecast t …
- 世界のインテリジェントビデオ解析市場動向（2012-2016）TechNavio’s analysts forecast the Global Intelligent Video Analytics market to grow at a CAGR of 31.4 percent over the period 2012-2016. One of the key factors contributing to this market growth is the need for advanced video monitoring capabilities. The Global Intelligent Video Analytics market has also been witnessing the increasing use of IVA for market analysis. However, the high cost of imple …
